Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, October 12, 2023
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
Samantha Semenkow Initiated (TSVT) at Strong Buy and Held Target at $13 on, Oct 12th, 2023
Samantha Semenkow of Citigroup, Initiated "2seventy bio, Inc." (TSVT) at Strong Buy and Held Target at $13 on, Oct 12th, 2023.
Samantha has made no other calls on TSVT in the last 4 months.
There are 4 other peers that have a rating on TSVT. Out of the 4 peers that are also analyzing TSVT, 3 agree with Samantha's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kelsey Goodwin of "Guggenheim" Downgraded from Strong Buy to Hold on, Wednesday, September 13th, 2023
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Held Target at $5 on, Wednesday, September 13th, 2023
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $13 on, Friday, July 28th, 2023
This is the rating of the analyst that currently disagrees with Samantha
- David Nierengarten of "Wedbush" Maintained at Buy with Decreased Target to $22 on, Friday, July 28th, 2023
